IRIS Accounts Production v23.1.5.20 11715403 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh117154032022-03-31117154032023-03-31117154032022-04-012023-03-31117154032021-03-31117154032021-04-012022-03-31117154032022-03-3111715403ns15:EnglandWales2022-04-012023-03-3111715403ns14:PoundSterling2022-04-012023-03-3111715403ns10:Director12022-04-012023-03-3111715403ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111715403ns10:SmallEntities2022-04-012023-03-3111715403ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111715403ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111715403ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3111715403ns10:FullAccounts2022-04-012023-03-3111715403ns10:Director22022-04-012023-03-3111715403ns10:RegisteredOffice2022-04-012023-03-3111715403ns5:CurrentFinancialInstruments2023-03-3111715403ns5:CurrentFinancialInstruments2022-03-3111715403ns5:ShareCapital2023-03-3111715403ns5:ShareCapital2022-03-3111715403ns5:RetainedEarningsAccumulatedLosses2023-03-3111715403ns5:RetainedEarningsAccumulatedLosses2022-03-3111715403ns5:PlantMachinery2022-04-012023-03-3111715403ns5:PlantMachinery2022-03-3111715403ns5:PlantMachinery2023-03-3111715403ns5:PlantMachinery2022-03-31
REGISTERED NUMBER: 11715403 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

WESSEX ENDOCRINE SOLUTIONS LTD

WESSEX ENDOCRINE SOLUTIONS LTD (REGISTERED NUMBER: 11715403)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


WESSEX ENDOCRINE SOLUTIONS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTORS: Dr T I L Richardson
Mrs C E Richardson





REGISTERED OFFICE: 28a The Hundred
Romsey
Hampshire
SO51 8BW





REGISTERED NUMBER: 11715403 (England and Wales)





ACCOUNTANTS: Kumar Associates
Chartered Certified Accountants
28a The Hundred
Romsey
Hampshire
SO51 8BW

WESSEX ENDOCRINE SOLUTIONS LTD (REGISTERED NUMBER: 11715403)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,235 342

CURRENT ASSETS
Debtors 5 1,897 18,777
Cash at bank 10,368 26,072
12,265 44,849
CREDITORS
Amounts falling due within one year 6 5,289 19,840
NET CURRENT ASSETS 6,976 25,009
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,211

25,351

CAPITAL AND RESERVES
Called up share capital 150 150
Retained earnings 8,061 25,201
SHAREHOLDERS' FUNDS 8,211 25,351

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 September 2023 and were signed on its behalf by:





Dr T I L Richardson - Director


WESSEX ENDOCRINE SOLUTIONS LTD (REGISTERED NUMBER: 11715403)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1. STATUTORY INFORMATION

Wessex Endocrine Solutions Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 50% on reducing balance

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 1,617
Additions 2,128
At 31 March 2023 3,745
DEPRECIATION
At 1 April 2022 1,275
Charge for year 1,235
At 31 March 2023 2,510
NET BOOK VALUE
At 31 March 2023 1,235
At 31 March 2022 342

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,897 18,777

WESSEX ENDOCRINE SOLUTIONS LTD (REGISTERED NUMBER: 11715403)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 997 3,210
Taxation and social security 953 6,690
Other creditors 3,339 9,940
5,289 19,840